In patients with breast cancer, the effect of tamoxifen on survival is related to the expression of estrogen receptor (ER) in breast cancer cells, and the higher the expression the greater the benefit of treatment with tamoxifen [8]. This evidence concerns the gene ESR1 and breast carcinoma.